NewAmsterdam Pharma Company NV (NAMS) Company Profile & Statistics

NewAmsterdam Pharma Company NV
NAMS
(Nasdaq - US)
Closed
24.93
-0.04 (-0.16%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Open
24.70
High
25.12
Low
24.50

About NewAmsterdam Pharma Company NV

CEO

Michael Davidson

Headquarters

gooimeer 2-35

narrden, p7 1411 dc, netherlands

Auditor

Deloitte Accountants B.V.

Employees

Share Holders

Website

www.newamsterdampharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

NewAmsterdam Pharma Holding B.V. is a late clinical-stage company focused on the research and development of transformative oral therapies for major cardiometabolic diseases. NewAmsterdam Pharma Holding B.V., formerly known as Frazier Lifesciences Acquisition Corporation, is based in MENLO PARK, Calif.

NewAmsterdam Pharma Company NV Statistics

Valuation Measures

Market Capitalization ²	2.30B
Enterprise Value	1.87B
Enterprise Value/EBITDA (ttm)	-17.33
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	5.92
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	50.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-2101.11%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	8.13%
Return on Assets (ttm)	N/A

Income Statement

Revenue (ttm)	3.68M
Revenue Per Share (ttm)	0.04
Gross Profit (ttm)	3.68M
EBITDA (ttm)³	-108.02M
Net Income Avi to Common (ttm)	-132.77M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	-0.01
52-Week Change	162.42%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	90.02M
Dividend Yield	0.00%
Float ⁴	72.46M
% Held by Insiders	19.50%
% Held by Institutions	89.89%

Balance Sheet

Total Cash (mrq)	430.71M
Total Cash Per Share (mrq)	4.78
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	9.83%
Quick Ratio (mrq)	10.61%
Book Value Per Share (mrq)	4.30

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.15
Free Cash Flow (ytd)	-109.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

NewAmsterdam Pharma Company NV

Trade With A Regulated Broker